π§¬CPT Code 58571 - Laparoscopic Total Hysterectomy, Uterus β€250 g, with Removal of Tube(s) and/or Ovary(s)
Quick Reference
wRVU: 15.07 | Global Period: 90 days | Assistant Payable: β Yes | Uterus Weight: β€250 g | Adnexa Removal: β Included
π Clinical Description
CPT 58571 describes a laparoscopic surgical total hysterectomy β complete removal of the uterus and cervix via a minimally invasive laparoscopic approach β for a uterus weighing 250 grams or less, performed concurrently with removal of one or both fallopian tubes and/or ovaries (unilateral or bilateral salpingectomy, oophorectomy, or salpingo-oophorectomy).
This code sits within the 58570-58573 laparoscopic total hysterectomy family, where code selection hinges on two key clinical variables:
- Uterine weight β β€250 g vs. >250 g (documented by intraoperative weight or final pathology report)
- Adnexal removal β with or without removal of tube(s) and/or ovary(s)
The βtotalβ hysterectomy descriptor specifies that the cervix is removed along with the uterine corpus β distinguishing this from supracervical (subtotal) hysterectomy, in which the cervix is retained. The entirely laparoscopic approach means all dissection, ligation, and specimen extraction are performed through laparoscopic ports without a primary abdominal incision.
The Weight Threshold is Non-Negotiable for Code Selection
Uterine weight must be documented β either by the surgeonβs intraoperative specimen weight or by the final pathology report. The 250 g threshold is not a clinical estimate; it is a CPT code selection criterion. If uterine weight is not recorded, a query to the operating surgeon or pathologist is appropriate before finalizing the code. Defaulting to 58570 or 58571 (β€250 g) when weight is undocumented is a common audit risk.
π¬ Procedural Technique Overview
Laparoscopic Approach β Standard and Robotic-Assisted
The procedure is performed under general anesthesia in the dorsal lithotomy position. Key steps include:
-
Port placement β typically four trocars: one umbilical (10-12 mm camera port) and 2-3 ancillary ports (5-8 mm) in the lower abdomen; robotic cases use docking-specific port configurations
-
Uterine manipulation β a uterine manipulator (e.g., RUMI, V-Care) is placed vaginally to facilitate exposure and colpotomy
-
Adnexal dissection β bilateral or unilateral round ligament transection, infundibulopelvic (IP) or utero-ovarian (UO) ligament ligation and division; if ovary(s) retained, UO ligament is preserved
-
Bladder dissection β vesicouterine peritoneum incised, bladder reflected inferiorly to expose the cervicovaginal junction
-
Ureteral identification β critical step to prevent ureteral injury; ureters are traced to their entry into the bladder bilaterally
-
Uterine vessel skeletonization and coagulation β uterine arteries and veins are desiccated or stapled at the level of the internal os
-
Colpotomy β circumferential incision of the vaginal cuff at the cervicovaginal junction, guided by the uterine manipulator cup
-
Specimen extraction β uterus and adnexa delivered vaginally or via port site with morcellation if indicated (per ACOG/FDA morcellation guidance in benign disease)
-
Vaginal cuff closure β laparoscopic suturing of the vaginal cuff in a running or interrupted fashion; some surgeons close vaginally
Robotic-Assisted Variant
When performed with robotic assistance (da Vinci or similar platform), the same CPT code family applies. Robotic assistance is not separately reportable as an additional CPT code by the operating surgeon. The facility reports robot-related costs through the HCPCS Level II code S2900 (surgical technique using computer-assisted robotic system) or equivalent facility-specific codes. The surgeon bills 58571 with modifier -22 if operative time and complexity significantly exceed typical expectations due to the robotic platform and clinical complexity.
βοΈ Code Family - 58570 Through 58573
This is the Most Critical Distinction in This Code Family
All four codes describe laparoscopic total hysterectomy. Selection is determined exclusively by uterine weight and adnexal removal status. Never assume β always verify both variables from the operative report and/or pathology.
| Code | Uterine Weight | Adnexa Removed? | wRVU |
|---|---|---|---|
| 58570 | β€250 g | β No | ~13.63 |
| 58571 | β€250 g | β Yes | ~15.07 |
| 58572 | >250 g | β No | ~17.17 |
| 58573 | >250 g | β Yes | ~18.41 |
Clinical Context for Weight Threshold
The average uterus weighs approximately 60-80 g. A uterus enlarged by fibroids can range from 200 g to well over 1,000 g. Most laparoscopic hysterectomies β particularly those performed in straightforward benign disease β fall at β€250 g, making 58570 and 58571 the most commonly reported of the four. Uteri >250 g are typically associated with significant fibroid burden, adenomyosis, or other pathology enlarging the organ, and often require more complex operative technique.
β Procedure Includes
- Complete laparoscopic removal of the uterus and cervix (total hysterectomy)
- Concurrent laparoscopic removal of one or both fallopian tubes (salpingectomy) and/or one or both ovaries (oophorectomy) or combined salpingo-oophorectomy (BSO or unilateral SO)
- All laparoscopic port placement and closure
- Uterine manipulator placement and use (intraoperative)
- dissection, ligation, and division of uterine supporting ligaments (round, broad, cardinal, uterosacral)
- Uterine vessel ligation/coagulation
- Colpotomy and vaginal cuff closure (laparoscopic or vaginal)
- Intraoperative hemostasis within the operative field
- Specimen removal (vaginal extraction, endobag retrieval, or port-site extraction)
- Routine intraoperative cystoscopy if performed to confirm ureteral integrity β NOTE: some payers bundle routine cystoscopy (52000) into the hysterectomy; confirm per payer LCD
β Excludes / Do Not Report Separately
| Code | Description | Relationship to 58571 |
|---|---|---|
| 58570 | Laparoscopic total hysterectomy, uterus β€250 g, WITHOUT adnexa | Mutually exclusive with 58571; adnexa either removed (β 58571) or not (β 58570) |
| 58572 | Laparoscopic total hysterectomy, uterus >250 g, WITHOUT adnexa | Different weight tier; do not report with 58571 |
| 58573 | Laparoscopic total hysterectomy, uterus >250 g, WITH adnexa | Different weight tier; do not report with 58571 |
| 58661 | Laparoscopic removal of adnexal structures (tube/ovary) | Bundled into 58571; adnexal removal is included in the descriptor β never separately report 58661 with 58571 |
| 49320 | Diagnostic laparoscopy | Bundled; always included in the surgical laparoscopy |
| 58662 | Laparoscopic fulguration/excision of pelvic lesions | May be separately reported IF the endometriosis or lesion excision is a separately distinct, documented procedure beyond the scope of the hysterectomy β requires modifier -59 and thorough operative note documentation; subject to CCI review |
| 44970 | Laparoscopic appendectomy | May be separately reported when performed for a distinct indication with separate documentation; requires -59 modifier |
| 58100 | Endometrial biopsy | Typically a preoperative procedure; do not report on the same date as hysterectomy |
| 57000 | Colpotomy | Included in the vaginal cuff work of the total hysterectomy |
| 52000 | Cystoscopy | Bundled by many payers when performed as routine confirmation of ureteral integrity during hysterectomy; separately reportable only when therapeutic or diagnostic cystoscopy is performed for a distinct indication |
58661 Bundling β Most Common Billing Error
The single most frequently cited unbundling error in gynecologic surgery coding is separately billing 58661 (laparoscopic adnexectomy) alongside 58571. Because 58571βs descriptor explicitly includes removal of tube(s) and/or ovary(s), 58661 is inherently bundled. This triggers a Column 1/Column 2 CCI edit and will be recouped on audit. Never report both.
π³ Code Tree - Female Genital System / Laparoscopic Hysterectomy
CPT 58000-58999 Surgery: Female Genital System
β
βββ 58150-58294 Open Hysterectomy Procedures
β βββ 58150 Total abdominal hysterectomy (TAH), with or without tubes/ovaries β€250 g
β βββ 58152 TAH with colpo-urethropexy
β βββ 58180 Supracervical abdominal hysterectomy (SAH)
β βββ 58200 TAH with partial vaginectomy, pelvic node sampling
β βββ 58210 Radical abdominal hysterectomy (Wertheim) with pelvic lymphadenectomy
β βββ 58240 Pelvic exenteration for gynecologic malignancy
β
βββ 58260-58294 Vaginal Hysterectomy
β βββ 58260 Vaginal hysterectomy, uterus β€250 g
β βββ 58262 Vaginal hysterectomy, uterus β€250 g, with tube(s)/ovary(s)
β βββ 58263 Vaginal hysterectomy, β€250 g, with tube(s)/ovary(s), enterocele repair
β βββ 58267 Vaginal hysterectomy, β€250 g, with colporraphy
β βββ 58270 Vaginal hysterectomy, β€250 g, with enterocele repair
β βββ 58290 Vaginal hysterectomy, uterus >250 g
β βββ 58291 Vaginal hysterectomy, >250 g, with tube(s)/ovary(s)
β βββ 58292 Vaginal hysterectomy, >250 g, with tube(s)/ovary(s), enterocele repair
β βββ 58293 Vaginal hysterectomy, >250 g, with colporraphy
β βββ 58294 Vaginal hysterectomy, >250 g, with enterocele repair
β
βββ 58541-58544 Laparoscopic Supracervical Hysterectomy (LASH)
β βββ 58541 LASH, uterus β€250 g
β βββ 58542 LASH, uterus β€250 g, with tube(s)/ovary(s)
β βββ 58543 LASH, uterus >250 g
β βββ 58544 LASH, uterus >250 g, with tube(s)/ovary(s)
β
βββ 58570-58573 Laparoscopic TOTAL Hysterectomy (TLH) β THIS FAMILY
β βββ 58570 TLH, uterus β€250 g
β βββ βΆβΆ 58571 ββ TLH, uterus β€250 g, WITH tube(s)/ovary(s) β YOU ARE HERE
β βββ 58572 TLH, uterus >250 g
β βββ 58573 TLH, uterus >250 g, WITH tube(s)/ovary(s)
β
βββ 58550-58554 Laparoscopic Myomectomy
β βββ 58552 Laparoscopic myomectomy, with morcellation, intramural fibroids >5 cm
β βββ 58554 Laparoscopic myomectomy with morcellation; any size, if 4 or more fibroids
β
βββ 58600-58673 Laparoscopic / Other Adnexal
β βββ 58661 Laparoscopic removal of adnexal structures (oophorectomy / salpingectomy)
β βββ 58662 Laparoscopic fulguration/excision of pelvic lesions (endometriosis)
β βββ 58673 Laparoscopic salpingostomy (salpingoneostomy)
β
βββ +38900 Intraoperative sentinel lymph node identification (add-on; when applicable for oncologic cases)
π° RVU & Reimbursement Profile
| Component | Value |
|---|---|
| Work RVU (wRVU) | ~15.07 |
| Global Period | 090 (90 days) |
| Assistant Surgeon (Modifier -80) | β Payable |
| Co-Surgeon (Modifier -62) | β Payable when two surgeons each perform a distinct part (e.g., complex oncologic pelvic dissection) |
| Team Surgery | β Not applicable |
| Bilateral Indicator | 3 - Concept does not apply |
| Modifier 51 Exempt | β No (subject to multiple procedure rules when additional procedures reported) |
| PC/TC Split | β Procedure code only |
| Anesthesia | General; anesthesiologist bills separately (~13 base units) |
wRVU Verification
wRVU values are updated annually in the CMS Medicare Physician Fee Schedule (MPFS) Final Rule. The value shown (~15.07) reflects recent MPFS data and should be verified against the current calendar year MPFS Relative Value File available on CMS.gov. Significant RVU revisions occurred in the 2021 E/M restructuring and periodic specialty-specific reviews.
π·οΈ Modifier Reference
| Modifier | Name | When to Apply with 58571 |
|---|---|---|
| -22 | Increased Procedural Services | Unusually increased complexity β dense adhesions from prior surgeries/endometriosis, prior pelvic radiation, conversion challenges, significantly prolonged operative time; must document in op note with specific reasons |
| -51 | Multiple Procedures | When additional distinct procedures are performed in the same operative session alongside 58571; subject to 50% reduction on lesser procedures per Medicare |
| -52 | Reduced Services | Procedure partially completed (e.g., converted to open without completing laparoscopic portion; only one adnexa removed when bilateral intended due to adverse intraoperative finding) |
| -53 | Discontinued Procedure | Procedure abandoned after initiation due to patient safety concerns |
| -59 | Distinct Procedural Service | When a separately reportable service (e.g., endometriosis excision, appendectomy) is performed and documentation supports a distinct procedure at a separate site |
| -80 | Assistant Surgeon | Physician assistant surgeon; this code is assistant-payable |
| -81 | Minimum Assistant | When resident or mid-level assists only a minor portion |
| -62 | Co-Surgeons | Two surgeons each performing distinct, required portions (typically in gynecologic oncology cases with complex dissection) |
| -47 | Anesthesia by Surgeon | Rare; documents surgeon administered anesthesia; virtually never applicable in this context |
| -32 | Mandated Services | When procedure is court-ordered or required by payer or governmental authority |
Modifier -22 Documentation Requirements
For -22 to be supported and reimbursed, the operative report must explicitly document:
- The specific findings that increased complexity (e.g., βdense adhesions from prior cesarean section obliterating vesicouterine space,β βstage IV endometriosis with complete cul-de-sac obliteration,β βfrozen pelvis requiring ureterolysisβ)
- Quantified increased operative time vs. typical expectation
- The specific additional work performed beyond the standard procedure Vague statements such as βdifficult caseβ or βcomplicated anatomyβ are insufficient and will not support modifier -22 reimbursement. Expect a 20-30% additional payment when supported β payers will request operative records for review.
π©Ί Common ICD-10-CM Pairings
Leiomyoma / Uterine Fibroids
| ICD-10 Code | Description | HCC? | Notes |
|---|---|---|---|
| D25.0 | Submucous leiomyoma of uterus | β No | Submucosal; most symptomatic fibroid type |
| D25.1 | Intramural leiomyoma of uterus | β No | Most common fibroid location overall |
| D25.2 | Subserous leiomyoma of uterus | β No | Pedunculated variants common |
| D25.9 | Leiomyoma of uterus, unspecified | β No | Use specific subtype when documented |
Fibroid Coding Pearl
Code the most specific subtype of leiomyoma documented in the clinical record or operative report. If multiple fibroid types are present (e.g., both intramural and subserous), code each separately. All leiomyoma codes are benign β they carry no HCC weight but are critical for DRG sequencing and medical necessity.
Abnormal Uterine Bleeding (AUB)
| ICD-10 Code | Description | HCC? | Notes |
|---|---|---|---|
| N92.0 | Excessive and frequent menstruation with regular cycle | β No | Menorrhagia with regular cycle (AUB-H per FIGO classification) |
| N92.1 | Excessive and frequent menstruation with irregular cycle | β No | Menometrorrhagia |
| N92.3 | Ovulation bleeding | β No | Mid-cycle spotting |
| N92.4 | Excessive bleeding in premenopausal period | β No | Perimenopausal AUB |
| N93.0 | Postcoital and contact bleeding | β No | Rule out cervical pathology |
| N93.8 | Other specified abnormal uterine and vaginal bleeding | β No | FIGO AUB categories not elsewhere classified |
| N93.9 | Abnormal uterine and vaginal bleeding, unspecified | β No | Use specific code when documented |
| N85.00 | Endometrial hyperplasia, unspecified | β No | Often precursor concern driving surgical decision |
| N85.01 | Benign endometrial hyperplasia | β No | Without atypia |
| N85.02 | Endometrial intraepithelial neoplasia (EIN) | β No | Atypical endometrial hyperplasia; high AH-to-cancer conversion risk |
Endometriosis
| ICD-10 Code | Description | HCC? | Notes |
|---|---|---|---|
| N80.0 | Endometriosis of uterus (adenomyosis) | β No | Adenomyosis specifically; often co-coded with uterine enlargement |
| N80.1 | Endometriosis of ovary | β No | Endometrioma; often bilateral |
| N80.2 | Endometriosis of fallopian tube | β No | Less common site |
| N80.3 | Endometriosis of pelvic peritoneum | β No | Most common pelvic implant location |
| N80.4 | Endometriosis of rectovaginal septum and vagina | β No | Deep infiltrating endometriosis |
| N80.5 | Endometriosis of intestine | β No | Bowel involvement; adds complexity β consider modifier -22 |
| N80.9 | Endometriosis, unspecified | β No | Use specific site when documented |
Adnexal Pathology
| ICD-10 Code | Description | HCC? | Notes |
|---|---|---|---|
| N83.20 | Unspecified ovarian cysts | β No | Functional or simple cyst NOS |
| N83.201 | Unspecified ovarian cyst, right side | β No | Use laterality when documented |
| N83.202 | Unspecified ovarian cyst, left side | β No | |
| N83.10 | Corpus luteum cyst, unspecified side | β No | Hemorrhagic corpus luteum |
| N83.512 | Torsion of left ovary and ovarian pedicle | β No | Emergency indication; drives urgent/emergent coding |
| N83.521 | Torsion of right fallopian tube | β No | |
| Q50.01 | Congenital absence of ovary, unilateral | β No | Relevant when contralateral oophorectomy planned |
Malignant Neoplasms
| ICD-10 Code | Description | HCC? | HCC Category (v28) | Notes |
|---|---|---|---|---|
| C54.1 | Malignant neoplasm of endometrium | β Yes | Cancer HCC | Most common gynecologic malignancy in the US; SLN mapping (+38900) often added |
| C54.2 | Malignant neoplasm of myometrium | β Yes | Cancer HCC | Uterine sarcoma variant |
| C54.3 | Malignant neoplasm of fundus uteri | β Yes | Cancer HCC | |
| C55 | Malignant neoplasm of uterus, part unspecified | β Yes | Cancer HCC | Use specific subsite when available |
| C56.1 | Malignant neoplasm of right ovary | β Yes | Cancer HCC | 58571 may be used in early-stage ovarian CA; more advanced cases may require 58210 |
| C56.2 | Malignant neoplasm of left ovary | β Yes | Cancer HCC | |
| C56.3 | Malignant neoplasm of bilateral ovaries | β Yes | Cancer HCC | |
| C57.00 | Malignant neoplasm of unspecified fallopian tube | β Yes | Cancer HCC | Primary fallopian tube carcinoma; rare |
| D39.0 | Neoplasm of uncertain behavior of uterus | β No | Borderline/uncertain β awaiting definitive histology | |
| D39.10 | Neoplasm of uncertain behavior, unspecified ovary | β No | Borderline ovarian tumor |
Secondary / Metastatic Diagnoses
| ICD-10 Code | Description | HCC? | HCC Category (v28) | Notes |
|---|---|---|---|---|
| C77.5 | Secondary malignant neoplasm, intrapelvic lymph nodes | β Yes - HCC 17 | Metastatic Cancer | Confirmed pelvic nodal metastasis |
| C79.60 | Secondary malignant neoplasm, unspecified ovary | β Yes - HCC 17 | Metastatic Cancer | Ovarian metastasis from another primary (e.g., Krukenberg tumor from gastric CA) |
| C78.6 | Secondary malignant neoplasm of retroperitoneum and peritoneum | β Yes - HCC 17 | Metastatic Cancer | Peritoneal carcinomatosis |
Other Common Co-Diagnoses
| ICD-10 Code | Description | HCC? | Notes |
|---|---|---|---|
| Z30.2 | Encounter for sterilization | β No | When hysterectomy is performed partly for permanent sterilization intent |
| N97.9 | Female infertility, unspecified | β No | When procedure relates to evaluation of infertility-related pathology |
| Z17.0 | Estrogen receptor positive status | β No | Important secondary for oncologic cases |
| Z85.42 | Personal history of malignant neoplasm of other female genital organs | β No | Prior GYN malignancy history relevant to current surgery |
| Z84.81 | Family history of carrier of genetic disease (e.g., BRCA) | β No | Prophylactic/risk-reducing BSO context |
| Z15.01 | Genetic susceptibility to malignant neoplasm of breast (BRCA1) | β No | Prophylactic BSO for BRCA1/2 carriers is a primary indication for adnexal removal |
| Z15.02 | Genetic susceptibility to malignant neoplasm of ovary (BRCA2) | β No |
HCC Mapping Note - v28
All primary uterine and ovarian malignancy codes (C54.x, C55, C56.x) map to a cancer-category HCC under CMS-HCC Model v28, elevating RAF scores significantly in Medicare Advantage populations. Secondary malignancy codes (C77.5, C78.6, C79.60) map to HCC 17 - Metastatic Cancer and Acute Leukemia, which carries one of the highest RAF weights in the model. Accurate capture of confirmed malignant and metastatic diagnoses is critical in oncologic hysterectomy cases for appropriate risk adjustment.
π₯ MS-DRG Considerations (Inpatient)
Inpatient Facility Reminder
In the DRG-based inpatient setting, CPT 58571 is not used. The ICD-10-PCS equivalent codes are submitted instead. MS-DRG assignment is driven by:
- Principal Diagnosis (the condition chiefly responsible for admission)
- ICD-10-PCS procedure codes (which surgical grouping the DRG falls into)
- CC/MCC status of secondary diagnoses
Non-Malignant Indications (Fibroids, AUB, Endometriosis)
| MS-DRG | Title | GMLOS | Key Driver |
|---|---|---|---|
| 742 | Uterine & Adnexa Procedures for Non-Malignancy with CC/MCC | ~2.9 days | CC or MCC secondary diagnosis present |
| 743 | Uterine & Adnexa Procedures for Non-Malignancy w/o CC/MCC | ~1.7 days | No CC/MCC; clean case |
Malignant Indications (Endometrial CA, Ovarian CA)
| MS-DRG | Title | GMLOS | Key Driver |
|---|---|---|---|
| 734 | Pelvic Evisceration, Radical Hysterectomy, Radical Vulvectomy with MCC | ~9.2 days | Radical procedures; very high complexity |
| 735 | Pelvic Evisceration, Radical Hysterectomy, Radical Vulvectomy with CC | ~5.1 days | |
| 736 | Pelvic Evisceration, Radical Hysterectomy, Radical Vulvectomy w/o CC/MCC | ~2.9 days | |
| 743 | Uterine & Adnexa Procedures for Ovarian or Adnexal Malignancy with MCC | ~6.1 days | Ovarian/adnexal CA; MCC secondary (e.g., sepsis, respiratory failure) |
| 744 | Uterine & Adnexa Procedures for Ovarian or Adnexal Malignancy with CC | ~4.0 days | CC secondary |
| 745 | Uterine & Adnexa Procedures for Ovarian or Adnexal Malignancy w/o CC/MCC | ~2.5 days | Clean malignancy case |
| 746 | Uterine & Adnexa Procedures for Non-Ovarian/Adnexal Malignancy with MCC | ~7.4 days | Endometrial CA with major complication |
| 747 | Uterine & Adnexa Procedures for Non-Ovarian/Adnexal Malignancy with CC | ~4.3 days | Endometrial CA with CC |
| 748 | Uterine & Adnexa Procedures for Non-Ovarian/Adnexal Malignancy w/o CC/MCC | ~2.6 days | Endometrial CA, uncomplicated |
CC/MCC Capture β Gynecologic Oncology Inpatients
Secondary Diagnosis Code CC/MCC Status Severe (protein-calorie) malnutrition E43 MCC Moderate malnutrition E44.0 CC Anemia in neoplastic disease D63.0 CC Postoperative urinary retention R33.9 CC Ileus, postoperative K56.0 CC Pulmonary embolism (PE) I26.09 MCC DVT, lower extremity I82.401 CC Wound dehiscence, surgical T81.31XA CC Dehydration E86.0 CC Sepsis (postoperative) A41.9 MCC Hyponatremia E87.1 CC In gynecologic oncology admissions, malnutrition (E43, E44.0) is frequently present but underdocumented. A clinical query to the attending when albumin <3.0, BMI <18.5, or nutritional decline is noted in the record can appropriately elevate DRG tier and is a legitimate and high-yield CDI opportunity.
π§ ICD-10-PCS Equivalents (Inpatient Facility Coding)
In the inpatient DRG setting, 58571 maps to a combination of ICD-10-PCS codes that must be reported individually for each distinct body part removed.
PCS Root Operation: Resection (T)
Why Resection (T) and Not Excision (B)?
Resection (T) is the correct root operation when the entire body part is removed β uterus, cervix, ovary, or fallopian tube taken in its entirety. Excision (B) would be used only if a portion of the body part remains (e.g., wedge resection of an ovary). In total hysterectomy with BSO, all body parts are removed entirely β Resection applies to all PCS codes.
Core PCS Codes for 58571 (Laparoscopic Total Hysterectomy with BSO)
| PCS Code | Description | Notes |
|---|---|---|
0UT94ZZ | Resection of Uterus, Percutaneous Endoscopic Approach | Always required β total hysterectomy |
0UTA4ZZ | Resection of Uterine Supporting Structure (Cervix included in uterus code for total hyst) | Cervix is included within 0UT94ZZ for total hysterectomy per PCS convention |
0UT74ZZ | Resection of Right Fallopian Tube, Percutaneous Endoscopic | Right salpingectomy component |
0UT84ZZ | Resection of Left Fallopian Tube, Percutaneous Endoscopic | Left salpingectomy component |
0UT14ZZ | Resection of Right Ovary, Percutaneous Endoscopic | Right oophorectomy |
0UT04ZZ | Resection of Left Ovary, Percutaneous Endoscopic | Left oophorectomy |
0UT24ZZ | Resection of Bilateral Ovaries, Percutaneous Endoscopic | Use when both ovaries removed; may replace the two separate ovary codes per facility convention |
PCS Coding Convention - Unilateral vs. Bilateral Adnexa
- If both ovaries are removed: code
0UT24ZZ(Bilateral Ovaries) OR code each ovary separately (0UT14ZZ+0UT04ZZ) β follow your facilityβs ICD-10-PCS convention; some facilities prefer the bilateral code, others code each side- If only one ovary is removed: code the specific side only (
0UT14ZZright or0UT04ZZleft)- If both fallopian tubes are removed: code each tube separately (
0UT74ZZ+0UT84ZZ) β there is no bilateral fallopian tube body part value in ICD-10-PCS; tubes must be coded individually- If only one tube is removed: code the specific side only
PCS Character Analysis - 0UT94ZZ (Uterus Resection, Laparoscopic)
| Position | Character | Value | Definition |
|---|---|---|---|
| 1 | Section | 0 | Medical and Surgical |
| 2 | Body System | U | Female Reproductive System |
| 3 | Root Operation | T | Resection (complete removal of body part) |
| 4 | Body Part | 9 | Uterus |
| 5 | Approach | 4 | Percutaneous Endoscopic (laparoscopic) |
| 6 | Device | Z | No Device |
| 7 | Qualifier | Z | No Qualifier |
Robotic Approach PCS Note
Robotic-assisted laparoscopic procedures are coded with approach 4 (Percutaneous Endoscopic) in ICD-10-PCS β there is no distinct approach value for robotic-assisted surgery. The PCS codes are identical whether the laparoscopic procedure is performed with standard instruments or with robotic assistance.
Conversion to Open β Approach Change
If the laparoscopic procedure is converted to open (laparotomy) intraoperatively, the approach character changes from 4 (Percutaneous Endoscopic) to 0 (Open):
| PCS Code | Description |
|---|---|
0UT90ZZ | Resection of Uterus, Open Approach |
0UT10ZZ | Resection of Right Ovary, Open Approach |
0UT00ZZ | Resection of Left Ovary, Open Approach |
Note
Code the approach that reflects how the majority of the procedure was completed, or per ICD-10-PCS Official Guideline B3.2d, which addresses procedures converted from one approach to another.
π Coding Examples
Example 1 - Outpatient ASC: Symptomatic Fibroids, Laparoscopic Total Hysterectomy with BSO
Clinical Scenario: A 46-year-old female with symptomatic intramural leiomyomas (D25.1) and menorrhagia (N92.0) undergoes laparoscopic total hysterectomy with bilateral salpingo-oophorectomy at an outpatient ASC. No assistant surgeon. Uterine specimen weight per pathology: 187 g. Operative note documents bilateral adnexal removal. No adhesions or additional procedures. Patient discharged same day.
| Field | Code | Rationale |
|---|---|---|
| CPT - Primary | 58571 | TLH β€250 g (187 g) WITH bilateral adnexal removal |
| PDx | D25.1 | Intramural leiomyoma β primary indication; drives DRG if admitted |
| SDx | N92.0 | Menorrhagia; co-existing symptom driving surgical decision |
Note:
Example 2 - Outpatient Hospital: BRCA2 Carrier, Prophylactic BSO with Concurrent TLH
Clinical Scenario: A 42-year-old female with BRCA2 genetic susceptibility (Z15.02) elects prophylactic bilateral salpingo-oophorectomy. Due to concurrent AUB and endometrial hyperplasia (N85.02 β EIN with atypia), the gynecologist elects to perform laparoscopic total hysterectomy with BSO in the same session. Uterine weight: 72 g. Assistant surgeon scrubbed for the second half of the case.
| Field | Code | Rationale |
|---|---|---|
| CPT - Primary | 58571 | TLH β€250 g (72 g) WITH bilateral adnexal removal |
| CPT - Assistant | 58571-80 | Assistant surgeon; this code is assistant-payable |
| PDx | N85.02 | EIN (atypical hyperplasia) β most clinically significant condition driving hysterectomy |
| SDx | Z15.02 | BRCA2 genetic susceptibility β supports adnexal removal medical necessity |
| SDx | N93.8 | AUB, other specified β contributing indication |
Payer Note: For BRCA-related prophylactic cases, medical necessity documentation (genetic counseling note, positive genetic test result, NCCN guideline reference) must be included with any prior auth or supporting records submission.
Example 3 - Inpatient: Endometrial Carcinoma with SLN Mapping and Concurrent Pelvic Washings
Clinical Scenario: A 61-year-old female is admitted for laparoscopic total hysterectomy with BSO for endometrial carcinoma (C54.1) FIGO Stage I. Concurrent procedures: bilateral pelvic SLN mapping with ICG dye (+38900), pelvic washings submitted for cytology (58900 - not separately reported per bundling with hysterectomy). Uterine weight: 210 g. Concurrent diagnoses: moderate malnutrition (E44.0) and mild anemia (D64.9).
ICD-10-PCS (Inpatient Facility):
| Code | Description |
|---|---|
0UT94ZZ | Resection of Uterus, Percutaneous Endoscopic |
0UT74ZZ | Resection of Right Fallopian Tube, Percutaneous Endoscopic |
0UT84ZZ | Resection of Left Fallopian Tube, Percutaneous Endoscopic |
0UT24ZZ | Resection of Bilateral Ovaries, Percutaneous Endoscopic |
07B90ZX | Excision of Pelvic Lymphatic, Open, Diagnostic (right pelvic SLN) |
ICD-10-CM Diagnoses:
| Sequence | Code | Description | HCC / DRG Role |
|---|---|---|---|
| PDx | C54.1 | Malignant neoplasm of endometrium | Drives uterine malignancy DRG |
| SDx | C56.3 | Bilateral ovaries β if ovarian involvement noted | HCC - Cancer |
| SDx | E44.0 | Moderate protein-calorie malnutrition | CC - upgrades DRG |
| SDx | D63.0 | Anemia in neoplastic disease | CC - upgrades DRG |
| SDx | Z17.0 | Estrogen receptor positive (if documented) | Clinical context |
MS-DRG Assignment:
| Scenario | DRG | GMLOS |
|---|---|---|
| With E44.0 + D63.0 (CC) | 747 - Uterine & Adnexa Proc for Non-Ovarian Malignancy with CC | ~4.3 days |
| Without CC/MCC | 748 - Uterine & Adnexa Proc for Non-Ovarian Malignancy w/o CC/MCC | ~2.6 days |
| If MCC present (e.g., E43 severe malnutrition) | 746 - With MCC | ~7.4 days |
Outpatient/Physician Billing: CPT: 58571 + +38900 (SLN add-on) | Assistant: 58571-80
Example 4 - Complex Outpatient Case: Stage IV Endometriosis with Ureterolysis, Modifier -22
Clinical Scenario: A 38-year-old female with stage IV endometriosis (N80.3, N80.4), including complete cul-de-sac obliteration and bilateral ureteral involvement, undergoes laparoscopic total hysterectomy with bilateral salpingo-oophorectomy. The operative note documents: 4.5 hours operative time (typical: ~90 minutes), extensive adhesiolysis involving the rectovaginal septum, bilateral ureterolysis to free both ureters from endometriotic nodules, and resection of deep infiltrating endometriotic nodules of the rectovaginal septum. Uterine weight: 94 g.
| Field | Code | Rationale |
|---|---|---|
| CPT - Primary | 58571-22 | TLH β€250 g with bilateral adnexa; 22 for dramatically increased operative complexity β op note must detail all extraordinary findings |
| CPT - Endometriosis Excision | 58662-59 | Laparoscopic excision/fulguration of pelvic lesions (deep infiltrating endometriosis, rectovaginal nodule); 59 documents distinct service from hysterectomy |
| PDx | N80.4 | Endometriosis of rectovaginal septum β most severe and clinically dominant site |
| SDx | N80.3 | Endometriosis of pelvic peritoneum |
| SDx | N80.2 | Endometriosis of fallopian tube (if documented) |
Modifier -22 Audit Risk
This is one of the highest-audit modifier combinations in gynecologic surgery. Documentation must be airtight β the operative report should include: specific anatomical findings, estimated blood loss, operative time compared to typical, specific additional procedures performed beyond standard hysterectomy, and any intraoperative complications or near-miss events. Without this documentation granularity, the -22 payment will be recouped.
β οΈ Common Coding Pitfalls
-
Uterine weight not documented or verified: The single most impactful error β defaulting to β€250 g codes without verifying pathology weight. If the uterus weighs 312 g and 58571 is reported instead of 58573, this is a significant underpayment (wRVU difference of ~3.34) and an accuracy error. Always cross-reference the pathology report.
-
Separately reporting 58661 with 58571: Adnexal removal is explicitly included in 58571βs descriptor. Reporting 58661 for the salpingectomy or oophorectomy is unbundling and will trigger a CCI Column 1/Column 2 edit denial.
-
Confusing total vs. supracervical hysterectomy codes: 58571 = total (cervix removed). If the cervix was retained (LASH β laparoscopic supracervical hysterectomy), the correct family is 58541-58544. Always verify in the operative report whether the cervix was resected or retained.
-
Reporting 49320 (diagnostic laparoscopy) with 58571: A surgical laparoscopy always includes the diagnostic component. Never separately report a diagnostic laparoscopy with a surgical laparoscopy of the same region in the same session.
-
Omitting modifier -22 on genuinely complex cases: The flip side of the audit risk β failing to capture legitimate complexity (stage IV endometriosis, frozen pelvis, morbid obesity, prior pelvic radiation, multiple prior surgeries) means leaving significant reimbursement on the table. Document the clinical case for modifier -22 when operative complexity is truly extraordinary.
-
Incorrect PCS Resection vs. Excision root operation: In ICD-10-PCS, Resection (T) is used when the entire body part is removed. Using Excision (B) for total hysterectomy misrepresents the procedure and may cause incorrect DRG grouping.
-
Missing bilateral fallopian tube PCS codes: In ICD-10-PCS, there is no bilateral fallopian tube body part β each tube must be coded separately. Coding only one tube when bilateral salpingectomy was performed results in incomplete procedure capture.
-
Not querying for malnutrition in oncologic hysterectomy cases: Moderate malnutrition (E44.0) is a CC that upgrades DRG 748 to 747 in endometrial CA cases. Oncologic patients frequently have nutritional compromise β if lab values (albumin, prealbumin, BMI) suggest it and the physician hasnβt documented it, a CDI query is appropriate and high-yield.
π Sources
AMA CPT 2024 Professional Edition Β· CMS 2024 Medicare Physician Fee Schedule Final Rule (CMS-1784-F) and MPFS Relative Value File Β· CMS-HCC Risk Adjustment Model v28 (2024) Β· CMS MS-DRG Grouper v41.1 Definitions Manual Β· ICD-10-PCS Official Guidelines for Coding and Reporting FY2024, Sections B3 and B6 Β· ICD-10-CM Official Guidelines for Coding and Reporting FY2024, Section I.C.2 Β· CCI Edits Table, CMS Q1 2024 Β· ACOG Practice Bulletin No. 226: Intraoperative and Postoperative Hemorrhage During Gynecologic Surgery Β· NCCN Clinical Practice Guidelines: Uterine Neoplasms v1.2024 Β· AAPC CPC & CIC Study Curriculum 2024 Β· SGO Clinical Practice Statement: SLN Mapping in Endometrial Cancer, 2023
Crystal's MCW Coder Hub